D053660Chemicals & DrugsD12.776.543.750.705.852.420.600270.998158Receptors, Interleukin-13prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonCancer BiologyWake Forest School of MedicineWaldemarDebinskiWaldemar Debinski MD, PhD36.08959100000000-80.26859900000000201Debinski, WaldemarProfessorTieLiuTie F. Liu MD, PhD36.09032400000000-80.26649100000000981Liu, TieInstructorSurgery, Oncologytrue1ProfessorProfessortrue1InstructorInstructor12939468Liu TF, Tatter SB, Willingham MC, Yang M, Hu JJ, Frankel AEMolecular cancer therapeuticsLiu TF, Tatter SB, Willingham MC, Yang M, Hu JJ, Frankel AE. Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy. . 2003 Aug; 2(8):783-7.2003-08-01T00:00:002003Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy.15068667Madhankumar AB, Mintz A, Debinski WNeoplasia (New York, N.Y.)Madhankumar AB, Mintz A, Debinski W. Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2. Neoplasia. 2004 Jan-Feb; 6(1):15-22.Neoplasia2004-01-01T00:00:002004Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.17172420Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JRMolecular cancer therapeuticsMadhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. . 2006 Dec; 5(12):3162-9.2006-12-01T00:00:002006Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.12952292Mintz A, Gibo DM, Madhankumar AB, Debinski WJournal of neuro-oncologyMintz A, Gibo DM, Madhankumar AB, Debinski W. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma. J Neurooncol. 2003 Aug-Sep; 64(1-2):117-23.J Neurooncol2003-08-01T00:00:002003Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.14649887Liu TF, Cohen KA, Willingham MC, Tatter SB, Puri RK, Frankel AEJournal of neuro-oncologyLiu TF, Cohen KA, Willingham MC, Tatter SB, Puri RK, Frankel AE. Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture. J Neurooncol. 2003 Oct; 65(1):77-85.J Neurooncol2003-10-01T00:00:002003Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture.0.2481980.1205472research area of0.3025880.05620948subject area for